While it is possible that the DAPK1 promoter methylation mark may play a role in hereditary CLL, our study has shown that total RNA expression of DAPK1 is not a prognostic marker in sporadic, randomly selected CLL. Here, DAPK1 is linked to B-cell chronic lymphocytic leukemia.